Phase 0 15 trials
Phase 0
NCT07604207 Jul 2026 → Jul 2031 expected cardiovascular disorder Massachusetts General Hospital
Not yet recruiting
No outcome recorded
Phase 0
NCT07023861 Jul 2025 → Jul 2026 overdue breast cancer , gastric cancer , urothelial carcinoma Affiliated Hospital of Jiangnan University
Enrolling by invitation
No outcome recorded
Phase 0
NCT07023848 Jul 2025 → Jul 2026 overdue breast cancer , gastric cancer , urothelial carcinoma Affiliated Hospital of Jiangnan University
Enrolling by invitation
No outcome recorded
Phase 0
NCT07301801 Jun 2025 → Sep 2026 overdue cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Recruiting
No outcome recorded
Phase 0
NCT06455761 Apr 2024 → Apr 2025 neoplasm First Affiliated Hospital of Fujian Medical University
Unknown
No outcome recorded
Phase 0
NCT06455735 Mar 2024 → Dec 2025 neoplasm First Affiliated Hospital of Fujian Medical University
Unknown
No outcome recorded
Phase 0
NCT06014515 Feb 2024 → Aug 2028 expected cardiovascular disorder University of California, Davis
Recruiting
No outcome recorded
Phase 0
NCT06126705 Jul 2023 → May 2024 —
Affiliated Hospital of North Sichuan Medical College
Unknown
No outcome recorded
Phase 0
NCT05543954 Sep 2022 → Dec 2025 overdue lung neoplasm Peking Union Medical College Hospital
Recruiting
No outcome recorded
Phase 0
NCT05549024 Aug 2022 → Dec 2025 overdue brain neoplasm , breast cancer , prostate cancer Peking Union Medical College Hospital
Recruiting
No outcome recorded
Phase 0
NCT03295695 Dec 2020 → Dec 2021 female breast carcinoma , male breast carcinoma H. Lee Moffitt Cancer Center and Research Institute
Withdrawn
No outcome recorded
Phase 0
NCT02193425 Jun 2015 → May 2023 —
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed
No outcome recorded
Phase 0
NCT02003456 Dec 2013 → Aug 2014 myocardial infarction , myocardial ischemia University of Michigan
Completed
No outcome recorded
Phase 0
NCT01665196 Sep 2012 → Dec 2017 autoimmune disease Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 0
NCT00816335 Oct 2008 → Aug 2011 cancer of unknown primary site Ohio State University Comprehensive Cancer Center
Completed
No outcome recorded
Show 5 more trials Phase 1 9 trials
Phase 1
NCT07838649 Nov 2026 → Dec 2029 expected Hodgkins lymphoma , breast cancer , non-Hodgkin lymphoma Washington University School of Medicine
Not yet recruiting
No outcome recorded
Phase 1
NCT06203119 Mar 2024 → Dec 2025 cancer Peking University Cancer Hospital & Institute
Completed
No outcome recorded
Phase 1
NCT05121779 Nov 2021 → Dec 2025 overdue pulmonary fibrosis Peking Union Medical College Hospital
Recruiting
No outcome recorded
Phase 1
NCT03493789 Apr 2018 → Mar 2019 carcinoma , lung cancer Emory University
Completed
No outcome recorded
Phase 1
NCT03590769 Jun 2017 → Sep 2019 calcinosis , intermittent vascular claudication , peripheral arterial disease University of California, San Francisco
Completed
No outcome recorded
Phase 1
NCT02891616 Oct 2016 → Dec 2017 melanoma Washington University School of Medicine
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT02429804 Apr 2015 → May 2017 hormone-resistant prostate carcinoma , metastatic carcinoma in the bone , metastatic prostate carcinoma Stanford University
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT03195270 Nov 2014 → Jan 2022 chronic pain syndrome Stanford University
Completed
No outcome recorded
Phase 1
NCT03404414 Feb 2013 → Nov 2018 pituitary gland adenoma Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 1/2 3 trials
Phase 1/2
NCT04273555 Mar 2026 → Jun 2028 HER2 positive breast carcinoma University of Alabama at Birmingham
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT05506566 May 2022 → May 2025 neoplasm First Affiliated Hospital of Fujian Medical University
Unknown
No outcome recorded
Phase 1/2
NCT05515783 May 2022 → May 2024 neoplasm First Affiliated Hospital of Fujian Medical University
Unknown
No outcome recorded
Phase 2 19 trials · 1 missed
Phase 2
NCT07285993 Jun 2026 → Dec 2027 expected invasive lobular breast carcinoma Randy Yeh
Not yet recruiting
No outcome recorded
Phase 2
NCT07443696 Dec 2025 → Aug 2026 overdue cardiomyopathy , heart failure Sinotau Pharmaceutical Group
Recruiting
No outcome recorded
Phase 2
NCT06503146 Sep 2025 → Jun 2028 expected cholangiocarcinoma , gastric cancer , hepatocellular carcinoma , mesothelioma +6 National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT06956391 May 2025 → Jun 2030 expected cancer Akiva Mintz
Recruiting
No outcome recorded
Phase 2
NCT05709171 Jan 2023 → Jan 2025 digestive system neuroendocrine neoplasm , neuroendocrine carcinoma Rigshospitalet, Denmark
Unknown
No outcome recorded
Phase 2
NCT05396118 May 2022 → Aug 2024 breast cancer , lymphoma , neuroendocrine carcinoma , sarcoma Rigshospitalet, Denmark
Unknown
No outcome recorded
Phase 2
NCT04692103 Jul → Oct 2021 overdue estrogen-receptor positive breast cancer University of Washington
Active not recruiting
No outcome recorded
Phase 2
NCT03824535 Feb 2019 → Jul 2021 pulmonary coin lesion Andrei Iagaru
Completed
No outcome recorded
Phase 2
NCT03602911 Feb 2019 → Apr 2021 head and neck squamous cell carcinoma West Virginia University
Completed
No outcome recorded
Phase 2
NCT03173924 Jun 2017 → Feb 2028 expected metastatic prostate carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03123289 Mar 2017 → Oct 2020 —
Rutgers, The State University of New Jersey
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT02805608 Sep 2016 → Jan 2019 urinary bladder neoplasm Rigshospitalet, Denmark
Unknown
No outcome recorded
Phase 2
NCT02599194 Jul 2015 → Dec 2016 B-cell neoplasm , malignant mesothelioma , non-small cell lung carcinoma , renal cell carcinoma +1 Andrei Iagaru
Completed
No outcome recorded
Phase 2
NCT01507428 Feb 2012 → Aug 2020 non-small cell lung carcinoma National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT01471418 Dec 2011 → Oct 2012 temporomandibular joint disorder University of Pennsylvania
Withdrawn
No outcome recorded
Stop: Business
Phase 2
NCT01237054 Oct 2010 → Aug 2011 monoclonal gammopathy of uncertain significance , smoldering plasma cell myeloma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01824056 Aug 2010 → Jul 2013 Parkinson disease Chang Gung Memorial Hospital
Completed
No outcome recorded
Phase 2
NCT01890343 Sep 2009 → Dec 2012 Alzheimer disease , frontotemporal dementia Avid Radiopharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00001849 May 1999 → Apr 2019 ectopic Cushing syndrome Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed
No outcome recorded
Show 9 more trials Phase 3 3 trials
Phase 3
NCT06416852 Aug 2024 → Aug 2026 overdue non-small cell lung carcinoma Yantai LNC Biotechnology Singapore PTE. LTD.
Not yet recruiting
No outcome recorded
Phase 3
NCT04831619 Dec 2023 → Apr 2025 endometriosis Centre Hospitalier Universitaire de la Réunion
Completed
No outcome recorded
Phase 3
NCT03891914 Nov 2019 → Jan 2023 plasma cell myeloma University Hospital, Bordeaux
Completed
No outcome recorded
Phase 4 3 trials
Phase 4
NCT05463913 Jul 2022 → Jun 2025 overdue lung cancer University Medical Center Groningen
Recruiting
No outcome recorded
Phase 4
NCT03937583 Oct 2019 → Dec 2023 lung disorder , pulmonary embolism , venous thromboembolism Andalusian Public Foundation for Health Research in Seville
Unknown
No outcome recorded
Phase 4
NCT03549598 Jul 2018 → Oct 2019 cardiac sarcoidosis Mayo Clinic
Completed
No outcome recorded
Phase not applicable 16 trials
— NCT07589101 Jun 2026 → Jun 2027 expected breast cancer , lung cancer Peking University Cancer Hospital & Institute
Not yet recruiting
No outcome recorded
— NCT07553741 Apr → Dec 2025 breast cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Completed
No outcome recorded
— NCT06630845 Feb 2025 → Oct 2027 expected metastatic malignant neoplasm University of California, San Francisco
Recruiting
No outcome recorded
— NCT07366710 Nov 2024 → Oct 2027 expected NAFLD1 , glucose metabolism disease Rigshospitalet, Denmark
Active not recruiting
No outcome recorded
— NCT06429891 Aug 2024 → Dec 2026 expected neoplasm Hua Zhu
Recruiting
No outcome recorded
— NCT05999227 Jun → Dec 2023 rectal cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
No outcome recorded
— NCT05840094 May 2023 → May 2025 lung neoplasm Peking University First Hospital
Unknown
No outcome recorded
— NCT05803746 Jul 2022 → Jul 2024 colorectal cancer , lung cancer Peking University Cancer Hospital & Institute
Unknown
No outcome recorded
— NCT05436093 Jun 2022 → Dec 2026 expected neoplasm Peking University Cancer Hospital & Institute
Recruiting
No outcome recorded
— NCT05432947 Apr → Sep 2022 clear cell renal carcinoma Peking Union Medical College Hospital
Completed
No outcome recorded
— NCT05448404 Mar 2022 → May 2023 plasma cell myeloma First Hospital of China Medical University
Unknown
No outcome recorded
— NCT05884463 Apr 2021 → Feb 2023 pancreatic adenocarcinoma Zhejiang University
Completed
No outcome recorded
— NCT04219969 Sep 2018 → May 2024 spinal cord neoplasm M.D. Anderson Cancer Center
Completed
No outcome recorded
— NCT02678884 Oct 2014 → Nov 2028 expected head and neck squamous cell carcinoma University Health Network, Toronto
Recruiting
No outcome recorded
— NCT02305264 Mar 2012 → Sep 2018 primary progressive multiple sclerosis , relapsing-remitting multiple sclerosis , secondary progressive multiple sclerosis Assistance Publique - Hôpitaux de Paris
Completed
No outcome recorded
— NCT02149173 Sep 2010 → Dec 2018 estrogen-receptor positive breast cancer University of Washington
Terminated
No outcome recorded
Stop: Enrollment
Show 6 more trials Comparator or background therapy 18 trials
Phase 0
NCT04016818 Background Jun 2026 → Dec 2027 breast cancer Stanford University
Withdrawn
No outcome recorded
Stop: Business
Phase 0
NCT06717113 Comparator Apr → Dec 2025 overdue plasma cell myeloma Peking University First Hospital
Recruiting
No outcome recorded
Phase 0
NCT06740240 Comparator Mar 2024 → Jun 2026 overdue neoplasm First Affiliated Hospital of Fujian Medical University
Recruiting
No outcome recorded
Phase 0
NCT02405078 Background Oct 2015 → Oct 2022 diffuse large B-cell lymphoma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT01494012 Background Apr → Sep 2012 malignant epithelial tumor of ovary , malignant germ cell tumor of ovary , peritoneum cancer Stanford University
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT07848243 Background Feb 2026 → Jul 2027 expected breast cancer , cervical squamous cell carcinoma , cutaneous melanoma , digestive system cancer +1 Peking University Cancer Hospital & Institute
Recruiting
No outcome recorded
Phase 2
NCT05885854 Background Dec 2021 → Mar 2023 ischemic disease Sinotau Pharmaceutical Group
Completed
No outcome recorded
Phase 2
NCT03181867 Background Aug 2017 → Feb 2031 expected prostate cancer National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02455453 Background Apr 2015 → Jan 2019 breast cancer Washington University School of Medicine
Completed
No outcome recorded
Phase 3
NCT01394679 Comparator May → Dec 2025 overdue lung cancer Cell>Point LLC
Not yet recruiting
No outcome recorded
Phase 3
NCT06125028 Comparator May 2024 → Jul 2025 marginal zone lymphoma Pentixapharm AG
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT02074202 Comparator Feb 2014 → Mar 2015 hepatocellular carcinoma National Taiwan University Hospital
Unknown
No outcome recorded
Phase 4
NCT05641753 Background Dec 2022 → Jul 2027 expected type 1 diabetes mellitus NYU Langone Health
Recruiting
No outcome recorded
Phase 4
NCT04417998 Comparator Jun 2020 → Dec 2023 —
Mayo Clinic
Completed
No outcome recorded
— NCT05322512 Background May → Dec 2024 cancer Peking University Cancer Hospital & Institute
Unknown
No outcome recorded
— NCT06383598 Background Apr 2024 → May 2026 neoplasm Hua Zhu
Completed
No outcome recorded
— NCT05390021 Background Mar 2024 → Feb 2025 endometrial endometrioid adenocarcinoma , endometrial mixed adenocarcinoma , endometrial undifferentiated carcinoma , serous adenocarcinoma Massachusetts General Hospital
Withdrawn
No outcome recorded
Stop: Enrollment
— NCT00887718 Background Aug 2007 → Jun 2011 Hodgkins lymphoma , non-Hodgkin lymphoma University Health Network, Toronto
Completed
No outcome recorded
Show 13 more trials